Literature DB >> 6306001

Two distinct Ca2+ proteases (calpain I and calpain II) purified concurrently by the same method from rat kidney.

N Yoshimura, T Kikuchi, T Sasaki, A Kitahara, M Hatanaka, T Murachi.   

Abstract

Two molecular species of calpain (Ca2+-dependent cysteine proteinases) were concurrently purified from rat kidney, both to homogeneity. Calpain I and calpain II having low and high Ca2+ requirements, respectively, were clearly separated on DEAE-cellulose chromatography at pH 7.5, and thereafter they were purified by separate but almost identical procedures which included (NH4)2SO4 fractionation and successive chromatographies on TSK-Gel G 3000 SWG, blue Sepharose CL-6B, and DEAE-Bio-Gel A. The purification folds and activity yields were 6170-fold and 17.8% for calpain I and 4160-fold and 11.9% for calpain II. Ca2+ concentrations for half-maximal activation were 2 microM for calpain I and 200 microM for calpain II. The specific activity of calpain II on casein as the substrate was more than twice higher than that of calpain I. Both enzymes are heterodimers, each composed of 80,000-Da and 25,000-Da subunits. The amino acid compositions of calpain I and calpain II are very similar but not identical. Calpain II is more acidic (pI 4.6) than calpain I (pI 5.3). This paper is the first to describe parallel isolation and characterization of low and high Ca2+-requiring proteases from one single nonmuscular tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306001

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

2.  A simple one-step procedure for the separation of calpain I, calpain II and calpastatin.

Authors:  J O Karlsson; S Gustavsson; C Hall; E Nilsson
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

3.  Calcium ions and glycogen act synergistically as inhibitors of hepatic glycogen-synthase phosphatase.

Authors:  L Mvumbi; M Bollen; W Stalmans
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

4.  Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation.

Authors:  Hanshuang Shao; Jeff Chou; Catherine J Baty; Nancy A Burke; Simon C Watkins; Donna Beer Stolz; Alan Wells
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  High molecular weight kininogen is an inhibitor of platelet calpain.

Authors:  A H Schmaier; H Bradford; L D Silver; A Farber; C F Scott; D Schutsky; R W Colman
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Degradation of skeletal muscle plasma membrane proteins by calpain.

Authors:  S I Zaidi; H T Narahara
Journal:  J Membr Biol       Date:  1989-09       Impact factor: 1.843

7.  Endogenous, Ca(2+)-dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle.

Authors:  V Shoshan-Barmatz; S Weil; H Meyer; M Varsanyi; L M Heilmeyer
Journal:  J Membr Biol       Date:  1994-12       Impact factor: 1.843

8.  Calcium dependent thiol protease caldonopain and its specific endogenous inhibitor in Leishmania donovani.

Authors:  J Bhattacharya; R Dey; S C Datta
Journal:  Mol Cell Biochem       Date:  1993-09-08       Impact factor: 3.396

9.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Differential distribution of calpain in human lymphoid cells.

Authors:  R V Deshpande; J M Goust; N L Banik
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.